A study to investigate the use of benralizumab in patients with Chronic Spontaneous Urticaria Who are Symptomatic Despite the Use of Antihistamines (ARROYO)

Trial Identifier: D3259C00001
Sponsor: AstraZeneca
Collaborator:
IQVIA
NCTID:: NCT04612725
Start Date: October 2020
Primary Completion Date: October 2022
Study Completion Date: March 2023
Condition: Urticaria

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Bulgarian Translation
German Translation
Spanish Translation
Spanish (US) Translation
Japanese Translation
Korean Translation
Polish Translation

Trial Locations

Country Location
BG Haskovo, BG, 6300
BG Ruse, BG, 7013
BG Sofia, BG, 1000
BG Sofia, BG, 1463
BG Sofia, BG, 1680
BG Sofia, BG, 1606
DE Berlin, DE, 10117
DE Dresden, DE, 01307
DE Leipzig, DE, 04103
ES Alicante, ES, 03010
ES Barcelona, ES, 8003
ES Cordoba, ES, 14004
ES Madrid, ES, 28040
ES Manises, ES, 46940
JP Hiroshima-shi, JP, 734-8551
JP Kamimashikigun,, JP, 861-3106
JP Kawasaki-shi, JP, 211-0063
JP Kobe-shi, JP, 650-0017
JP Sakai-shi, JP, 593-8324
KR Seoul, KR, 6591
KR Seoul, KR, 06973
KR Seoul, KR, 03722
PL Gdańsk, PL, 80-546
PL Krakow, PL, 30-033
PL Poznań, PL, 60-214
PL Warszawa, PL, 02-507
PL Wrocław, PL, 50-449
US, AZ Scottsdale, AZ, US, 85260
US, CA Los Angeles, CA, US, 90025
US, CA Mission Viejo, CA, US, 92691
US, CA Newport Beach, CA, US, 92663
US, FL Miami, FL, US, 33173
US, FL Tampa, FL, US, 33606
US, GA Columbus, GA, US, 31904
US, MI Ypsilanti, MI, US, 48197
US, OH Cincinnati, OH, US, 45229
US, OH Cincinnati, OH, US, 45236
US, OK Norman, OK, US, 73071
US, TX Austin, TX, US, 78745